The American Journal of Human GeneticsGeneticsPeer-reviewed journal article
Leveraging gene co-regulation to identify gene sets enriched for disease heritability
Katherine M. SiewertiD, Samuel Sungil KimiD, Douglas W. YaoiD, Huwenbo ShiiD, Alkes L. PriceiD
Abstract
Identifying gene sets that are associated to disease can provide valuable biological knowledge, but a fundamental challenge of gene set analyses of GWAS data is linking disease-associated SNPs to genes. Transcriptome-wide association studies (TWAS) can be used to detect associations between the genetically predicted expression of a gene and disease risk, thus implicating candidate disease genes. However, causal disease genes at TWAS-associated loci generally remain unknown due to gene co-regulation, which leads to correlations across genes in predicted expression. We developed a new method, gene co-regulation score (GCSC) regression, to identify gene sets that are enriched for disease heritability explained by the predicted expression of causal disease genes in the gene set. GCSC regresses TWAS chi-square statistics on gene co-regulation scores reflecting correlations in predicted gene expression; GCSC determines that a gene set is enriched for disease heritability if genes with high co-regulation to the gene set have higher TWAS chi-square statistics than genes with low co-regulation to the gene set, beyond what is expected based on co-regulation to all genes. We verified via simulations that GCSC is well-calibrated, and well-powered to identify gene sets that are enriched for disease heritability explained by predicted expression. We applied GCSC to gene expression data from GTEx (48 tissues) and GWAS summary statistics for 43 independent diseases and complex traits (average N =344K), analyzing a broad set of biological pathways and specifically expressed gene sets. We identified many enriched gene sets, recapitulating known biology. For Alzheimers disease, we detected evidence of an immune basis, and specifically a role for antigen presentation, in analyses of both biological pathways and specifically expressed gene sets. Our results highlight the advantages of leveraging gene co-regulation within the TWAS framework to identify gene sets associated to disease.
- organism: human
- assay: GWAS summary statistics
- research focus: gene regulatory network inference
- research focus: differential expression
- research focus: GWAS / association mapping
- approach: statistical model
- Citations
- 21
- FWCI
- 1.31
- Field percentile
- top 22%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Modeling tissue co-regulation to estimate tissue-specific contributions to disease
Tiffany Amariuta, Katherine M. Siewert, Alkes L. Price·Nature GeneticsPeer-reviewed·Aug 14, 2023
- Partitioning gene-based variance of complex traits by gene score regression
Wenmin Zhang, Si Yi Li, … Yue Li·PLoS ONEPeer-reviewed·Aug 20, 2020
- Estimating the proportion of disease heritability mediated by gene expression levels
Luke Jen O’Connor, Alexander Gusev, … Alkes L. Price·bioRxiv·Mar 18, 2017
- Leveraging genome-wide effects on gene expression to identify disease-critical genes with trans-genetic components
Krishna Brunton, Michelle Franc Ragsac, Tiffany Amariuta·medRxiv·Feb 25, 2026
- Quantifying genetic effects on disease mediated by assayed gene expression levels
Douglas W. Yao, Luke Jen O’Connor, … Alexander Gusev·Nature GeneticsPeer-reviewed·May 18, 2020
- Integrating gene expression with summary association statistics to identify susceptibility genes for 30 complex traits
Nicholas Mancuso, Huwenbo Shi, … Bogdan Pasaniuc·bioRxiv·Sep 1, 2016